Analysen zu Novo Nordisk
| 25.04.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 24.04.24 | Novo Nordisk Outperform | Bernstein Research | |
| 25.03.24 | Novo Nordisk Overweight | Barclays Capital | |
| 11.03.24 | Novo Nordisk Overweight | Barclays Capital | |
| 08.03.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 08.03.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 07.03.24 | Novo Nordisk Overweight | Barclays Capital | |
| 06.03.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 05.03.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 01.03.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 28.02.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 27.02.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 19.02.24 | Novo Nordisk Overweight | Barclays Capital | |
| 09.02.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.02.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 05.02.24 | Novo Nordisk Overweight | Barclays Capital | |
| 05.02.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 01.02.24 | Novo Nordisk Overweight | Barclays Capital | |
| 01.02.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 31.01.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 24.01.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 17.01.24 | Novo Nordisk Overweight | Barclays Capital | |
| 16.01.24 | Novo Nordisk Buy | Jefferies & Company Inc. | |
| 12.01.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 10.01.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 08.01.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 02.01.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 18.12.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 18.12.23 | Novo Nordisk Overweight | Barclays Capital | |
| 08.12.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 05.12.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 05.12.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 14.11.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 12.11.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.11.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.11.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 02.11.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 17.10.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 16.10.23 | Novo Nordisk Overweight | Barclays Capital | |
| 13.10.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 09.10.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 20.09.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 18.09.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. |
Aktuelle Aktienanalysen
| 01.05.25 | DWS Group Overweight | JP Morgan Chase & Co. | |
| 01.05.25 | Santander Buy | UBS AG | |
| 01.05.25 | Deutsche Börse Neutral | JP Morgan Chase & Co. | |
| 01.05.25 | Linde Neutral | UBS AG | |
| 01.05.25 | Microsoft Buy | UBS AG | |
| 01.05.25 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 01.05.25 | Microsoft Overweight | JP Morgan Chase & Co. | |
| 01.05.25 | Meta Platforms Overweight | JP Morgan Chase & Co. | |
| 01.05.25 | London Stock Exchange Buy | UBS AG | |
| 01.05.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.05.25 | Microsoft Buy | Jefferies & Company Inc. | |
| 01.05.25 | Iberdrola Equal Weight | Barclays Capital | |
| 01.05.25 | TotalEnergies Overweight | Barclays Capital | |
| 01.05.25 | London Stock Exchange Outperform | RBC Capital Markets | |
| 01.05.25 | Glencore Overweight | Barclays Capital | |
| 01.05.25 | ArcelorMittal Overweight | Barclays Capital | |
| 01.05.25 | AIR France-KLM Underweight | Barclays Capital | |
| 01.05.25 | ams-OSRAM Equal Weight | Barclays Capital | |
| 01.05.25 | AIXTRON Equal Weight | Barclays Capital | |
| 01.05.25 | London Stock Exchange Buy | Jefferies & Company Inc. | |
| 01.05.25 | Rolls-Royce Buy | UBS AG | |
| 01.05.25 | DWS Group Neutral | Goldman Sachs Group Inc. | |
| 01.05.25 | UBS Buy | Goldman Sachs Group Inc. | |
| 01.05.25 | Airbus Neutral | UBS AG | |
| 01.05.25 | TotalEnergies Neutral | Goldman Sachs Group Inc. | |
| 01.05.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 01.05.25 | Glencore Buy | Goldman Sachs Group Inc. | |
| 01.05.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 01.05.25 | GSK Neutral | Goldman Sachs Group Inc. | |
| 01.05.25 | Inditex Buy | Goldman Sachs Group Inc. | |
| 01.05.25 | Nordex Buy | Goldman Sachs Group Inc. | |
| 01.05.25 | E.ON Hold | Jefferies & Company Inc. | |
| 01.05.25 | Adyen B.V. Parts Sociales Buy | Jefferies & Company Inc. | |
| 01.05.25 | Meta Platforms Buy | Jefferies & Company Inc. | |
| 01.05.25 | BP Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.05.25 | Glencore Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.05.25 | Microsoft Outperform | RBC Capital Markets | |
| 01.05.25 | Stellantis Overweight | JP Morgan Chase & Co. | |
| 01.05.25 | Adyen B.V. Parts Sociales Overweight | JP Morgan Chase & Co. | |
| 01.05.25 | DHL Group Overweight | JP Morgan Chase & Co. | |
| 01.05.25 | Meta Platforms Outperform | RBC Capital Markets | |
| 01.05.25 | Kering Sector Perform | RBC Capital Markets | |
| 01.05.25 | EssilorLuxottica Outperform | RBC Capital Markets | |
| 01.05.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.05.25 | HSBC Holdings Sector Perform | RBC Capital Markets | |
| 01.05.25 | HSBC Holdings Neutral | JP Morgan Chase & Co. | |
| 01.05.25 | GSK Neutral | UBS AG | |
| 01.05.25 | TotalEnergies Buy | UBS AG | |
| 01.05.25 | ams-OSRAM Buy | UBS AG | |
| 01.05.25 | Nemetschek Underweight | JP Morgan Chase & Co. |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.